Riskpilot← Back to searchSign inGet full accessSANDVIKEN DYREKLINIKK AS
ASActiveOrg 918783148Sandviksbodene 65B, 5035 BergenVeterinary activities · NACE 7500Est. 201716 employees
Revenue 2024
NOK 16,8M
-26% vs 2023
EBITDA margin
30.1%
-30% vs 2023
Equity ratio
46.9%
Financial strength
Net profit 2024
NOK 3,7M
-29% vs 2023
| Revenue | NOK 16,8M | -26% |
| EBITDA | NOK 5M | -30% |
| Net profit | NOK 3,7M | -29% |
| Total assets | NOK 8M | -39% |
| Equity | NOK 3,8M | +12415% |
| Employees | 16 | — |
Legal name
SANDVIKEN DYREKLINIKK AS
Org number
918783148
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
29. mars 2017
Share capital
NOK 30 000
Employees
16 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Eierskap og drift av dyreklinikk.
Address
Sandviksbodene 65B, 5035 Bergen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 026 | 20 293 | 19 568 | 22 783 | 16 768 |
| Staff expenses | −4 711 | −6 978 | −8 227 | −9 316 | −6 498 |
| EBITDA | 5 530 | 3 942 | 5 712 | 7 196 | 5 047 |
| Depreciation & amort. | −107 | −132 | −485 | −479 | −118 |
| EBIT | 5 423 | 3 810 | 5 227 | 6 718 | 4 929 |
| Net financials | 15 | 13 | 32 | 83 | −27 |
| Profit before tax | 5 438 | 3 823 | 5 259 | 6 801 | 4 903 |
| Tax | 1 177 | 845 | 1 164 | 1 547 | 1 178 |
| Net profit | 4 261 | 2 978 | 4 095 | 5 254 | 3 725 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 177 | 7 432 | 10 375 | 13 094 | 7 998 |
| Equity | 364 | 30 | 30 | 30 | 3 755 |
| Long-term debt | 3 | 50 | 9 | 0 | 0 |
| Short-term debt | 11 811 | 7 353 | 10 336 | 13 064 | 4 244 |
| Total debt | 11 813 | 7 402 | 10 345 | 13 064 | 4 244 |
EBITDA margin
30.1%
This company
15.8%
Market median
+91% vs market
20202024
Equity ratio
46.9%
This company
38.2%
Market median
+23% vs market
20202024
Return on equity
99.2%
This company
18.4%
Market median
+439% vs market
20202024
Net profit margin
22.2%
This company
8.1%
Market median
+174% vs market
20202024
Asset turnover
2.10×
This company
1.12×
Market median
+87% vs market
20202024
Debt / equity
1.13×
This company
0.62×
Market median
-82% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-09-30
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
KS Chief Executive Officer | Chief Executive Officer | 2017 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Chairman | 2017 – 2024 | |
| Board of Directors | 2025 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 | |
| Company | 50% | 50% | 2023 | |
| Company | 50% | 50% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Evidensia Dyrehelse As
SANDVIKEN DYREKLINIKK AS Board members of SANDVIKEN DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristine Skogseth-Jacobsen | Chief Executive Officer | 0 companies |
| Camilla Meltevik | Chairman | 0 companies |
| Are Borvik Knutsen | Chairman | 0 companies |
| Anders Hjelseng Gudevold | Board of Directors | 0 companies |
| Geir Vikvald | Board of Directors | 0 companies |
| Kari Anne Hole | Board of Directors | 0 companies |